The drug, known commercially as Hernexeos, won FDA accelerated approval in August as a once-daily, orally-administered TKI targeting HER2 (ERBB2)-mutant mNSCLC after prior systemic therapy
While occasional digestive discomfort is common, severe or long-lasting diarrhea should always be discussed with a doctor to avoid dehydration and other complications
Fortunately, peptide therapy offers a cutting-edge approach to accelerate your bodys natural healing processes
Sergey Terushkin, MD, FACS One of the biggest misunderstandings is confusing the return of an old injury with withdrawal
Abstract available from: Accessed December 17, 2015
Encapsulation of DDA-GSH-AuNCs into PLGA nanoparticles using the emulsion-evaporation method PLGA (30 mg) was dissolved in chloroform containing DDA-GSH-AuNCs (1.5 mL), and then emulsified into aqueous PVA solution (2.5% w/w, 5.0 mL) using sonication for 60 s (ultra-probe sonicator at 50 W, UP200Ht, Hielscher Ultrasonics, Teltow, Germany)